Behrenbruch Christian
Behrenbruch Christian, MD, GC, reported an open-market or private purchase at Telix Pharmaceuticals Ltd involving 33435.000000 shares for an estimated $497178.45. Reported holdings after the transaction were 20742935.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Apr 29, 2026
- Filing date
- May 07, 2026
How reported position traded is calculated
Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 20,709,500 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingTLX price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0001628280-26-031608 Ordinary Shares
- Transaction date
- Apr 29, 2026 Filed May 07, 2026, 01:32 AM · 8d delay
- Shares
- 33,435 sh $14.87 per share
- Estimated value
- $497k Computed from shares × price
- Holdings after
- 20,742,935 sh Indirect · Elk River Holdings Pty Ltd
Filing signal explanations
Badges describe filing facts only — not predictions.
+20 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - director_buy+6 points
is_director = true
Director open-market purchase. - repeat_buyer+8 points
repeat-buyer signal matched
Same insider bought again within the configured window. - delayed_filing-6 points
reporting_delay_days = 8
Filing delay exceeds the configured threshold.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
MD & Group CEO
- F1
The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.42 - $14.58, inclusive. The Reporting Person undertakes to provide to…
- F2
The purchase prices are reported in Australian Dollars.
- F3
Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd.
- F4
The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.54 - $14.72, inclusive. The Reporting Person undertakes to provide to…
0 other transactions
0 recent txs